358 related articles for article (PubMed ID: 7614506)
1. Importance of angiotensin-converting enzyme inhibitors in myocardial infarction and congestive heart failure: implications for clinical practice.
Pitt B
Cardiology; 1995; 86 Suppl 1():41-5. PubMed ID: 7614506
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II receptor antagonists in heart failure: rationale and design of the evaluation of losartan in the elderly (ELITE) trial.
Pitt B; Chang P; Timmermans PB
Cardiovasc Drugs Ther; 1995 Oct; 9(5):693-700. PubMed ID: 8573552
[TBL] [Abstract][Full Text] [Related]
4. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
Ahmed A
J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028
[TBL] [Abstract][Full Text] [Related]
5. ACE inhibitors in heart failure: prospects and limitations.
Pitt B
Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():285-90. PubMed ID: 9211022
[TBL] [Abstract][Full Text] [Related]
6. New competition in the realm of renin-angiotensin axis inhibition; the angiotensin II receptor antagonists in congestive heart failure.
Martineau P; Goulet J
Ann Pharmacother; 2001 Jan; 35(1):71-84. PubMed ID: 11197588
[TBL] [Abstract][Full Text] [Related]
7. Neurohormonal activation and congestive heart failure: today's experience with ACE inhibitors and rationale for their use.
Sigurdsson A; Swedberg K
Eur Heart J; 1995 Dec; 16 Suppl N():65-72. PubMed ID: 8682064
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibitors.
Brown NJ; Vaughan DE
Circulation; 1998 Apr; 97(14):1411-20. PubMed ID: 9577953
[TBL] [Abstract][Full Text] [Related]
9. ACE inhibitor use in elderly patients with systolic left ventricular dysfunction: problems and opportunities.
Pitt B
Br J Clin Pract Suppl; 1996 Jul; 84():11-6. PubMed ID: 8994996
[TBL] [Abstract][Full Text] [Related]
10. Rationale, background, and design of the randomized angiotensin receptor antagonist--angiotensin-converting enzyme inhibitor study (RAAS).
Pitt B; Chang P; Grossman W; Dunlay M; Timmermans PB
Am J Cardiol; 1996 Nov; 78(10):1129-31. PubMed ID: 8914876
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme inhibitors post-myocardial infarction.
Young JB
Cardiol Clin; 1995 Aug; 13(3):379-90. PubMed ID: 7585774
[TBL] [Abstract][Full Text] [Related]
12. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction.
Beckwith C; Munger MA
Ann Pharmacother; 1993 Jun; 27(6):755-66. PubMed ID: 8329800
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunction.
Sander GE; McKinnie JJ; Greenberg SS; Giles TD
Prog Cardiovasc Dis; 1999; 41(4):265-300. PubMed ID: 10362349
[TBL] [Abstract][Full Text] [Related]
14. Should angiotensin receptor blockers be added to angiotensin-converting enzyme inhibitors in the treatment of heart failure?
Ghanem FA; Movahed A
Rev Cardiovasc Med; 2005; 6(4):206-13. PubMed ID: 16379016
[TBL] [Abstract][Full Text] [Related]
15. ACE inhibitors in heart failure: an update.
Smith WH; Ball SG
Basic Res Cardiol; 2000; 95 Suppl 1():I8-14. PubMed ID: 11192359
[TBL] [Abstract][Full Text] [Related]
16. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
Pfeffer MA; McMurray JJ; Velazquez EJ; Rouleau JL; Køber L; Maggioni AP; Solomon SD; Swedberg K; Van de Werf F; White H; Leimberger JD; Henis M; Edwards S; Zelenkofske S; Sellers MA; Califf RM;
N Engl J Med; 2003 Nov; 349(20):1893-906. PubMed ID: 14610160
[TBL] [Abstract][Full Text] [Related]
17. Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism.
Brunner-La Rocca HP; Vaddadi G; Esler MD
J Am Coll Cardiol; 1999 Apr; 33(5):1163-73. PubMed ID: 10193712
[TBL] [Abstract][Full Text] [Related]
18. ACE inhibitors: myocardial infarction and congestive heart failure.
Cody RJ
Am Fam Physician; 1995 Nov; 52(6):1801-6. PubMed ID: 7484690
[TBL] [Abstract][Full Text] [Related]
19. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
Sigurdsson A
Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
[TBL] [Abstract][Full Text] [Related]
20. Oral angiotensin-converting-enzyme inhibitors.
Verme-Gibboney C
Am J Health Syst Pharm; 1997 Dec; 54(23):2689-703. PubMed ID: 9408513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
